Incretins have received a lot of attention as a relatively new treatment option for persons with type 2 diabetes mellitus.
What classes of incretin-based therapies are now available, and how are they currently being used in clinical practice? What advantages do they offer over older therapies?
Here, in his second podcast on incretins, is Louis Kuritzky, MD, Clinical Assistant Professor in the Department of Community Health and Family Medicine at the University of Florida in Gainesville. In his first podcast, Dr Kuritzky offers an update on the basics of incretin therapy.
| Incretins for Type 2 Diabetes Mellitus (Part 2) | |
Incretins for Type 2 Diabetes Mellitus (Part 2) |
